The see kidney disease targeted screening program for CKD

Clinical Journal of the American Society of Nephrology

Volumn 11, Issue 6, 2016, Pages 964-972

  Galbraith, Lauren E ^a   Ronksley, Paul E ^a   Barnieh, Lianne J ^b   Kappel, Joanne ^c   Manns, Braden J ^a,b   Samuel, Susan M ^b   Jun, Min ^b   Weaver, Rob ^b   Valk, Nadine ^d   Hemmelgarn, Brenda R ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF SASKATCHEWAN   (Canada)

^d Traffic Injury Research   (Canada)

Author keywords

Canada; Chronic; Chronic kidney disease; Creatinine; Glomerular filtration rate; Humans; Hypertension; Kidney; Prevalence; Renal insufficiency; Targeted screening

Indexed keywords

ADULT; ARTICLE; ATTITUDE TO HEALTH; CHRONIC KIDNEY FAILURE; COMMUNITY ASSESSMENT; CONTROLLED STUDY; DEMOGRAPHY; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; HUMAN; INTERVIEW; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MIDDLE AGED; PREVALENCE; RISK FACTOR; STAGING; AGED; BLOOD; CANADA; DIABETES MELLITUS; GENETICS; GLOMERULUS FILTRATION RATE; HYPERTENSION; PATIENT SELECTION; POINT OF CARE TESTING; PROCEDURES; VASCULAR DISEASE;

CREATININE;

ADULT; AGED; CANADA; CREATININE; DIABETES MELLITUS; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; MALE; MASS SCREENING; MIDDLE AGED; PATIENT SELECTION; POINT-OF-CARE TESTING; PREVALENCE; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; VASCULAR DISEASES;

EID: 84997821536     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.11961115     Document Type: Article

References (26)

1. Levey AS, Atkins R, Coresh J, Cohen EP, Collins AJ, Eckardt KU, Nahas ME, Jaber BL, Jadoul M, Levin A, Powe NR, Rossert J, Wheeler DC, Lameire N, Eknoyan G: Chronic kidney disease as a global public health problem: approaches and initiatives -a position statement from Kidney Disease Improving Global Outcomes. Kidney Int 72: 247–259, 2007
2. Levey AS, Coresh J: Chronic kidney disease. Lancet 379: 165– 180, 2012
3. Eckardt KU, Coresh J, Devuyst O, Johnson RJ, Köttgen A, Levey AS, Levin A: Evolving importance of kidney disease: from sub-specialty to global health burden. Lancet 382: 158–169, 2013
4. Arora P, Vasa P, Brenner D, Iglar K, McFarlane P, Morrison H, Badawi A: Prevalence estimates of chronic kidney disease in Canada: results of a nationally representative survey. CMAJ 185: E417–E423, 2013
5. Mills KT, Xu Y, Zhang W, Bundy JD, Chen CS, Kelly TN, Chen J, He J: A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010. Kidney Int 88: 950–957, 2015
6. Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M, McAlister F, Garg AX: Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol 17: 2034–2047, 2006
7. Akbari A, Clase CM, Acott P, Battistella M, Bello A, Feltmate P, Grill A, Karsanji M, Komenda P, Madore F, Manns BJ, Mahdavi S, Mustafa RA, Smyth A, Welcher ES: Canadian Society of Nephrology Commentary on the KDIGO Clinical Practice Guideline for CKD Evaluation and Management. Am J Kidney Dis 65: 177-205, 2015
8. Kidney Disease; Improving Global Outcomes (KDIGO) CKD Work Group: KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl 3: 1–150, 2013
9. James MT, Hemmelgarn BR, Tonelli M: Early recognition and prevention of chronic kidney disease. Lancet 375: 1296–1309, 2010
10. Manns B, Hemmelgarn B, Tonelli M, Au F, Chiasson TC, Dong J, Klarenbach S; Alberta Kidney Disease Network: Population based screening for chronic kidney disease: cost effectiveness study. BMJ 341: c5869, 2010
11. Komenda P, Ferguson TW, Macdonald K, Rigatto C, Koolage C, Sood MM, Tangri N: Cost-effectiveness of primary screening for CKD: a systematic review. Am J Kidney Dis 63: 789–797, 2014
12. Vassalotti JA, Li S, Chen SC, Collins AJ: Screening populations at increased risk of CKD: the Kidney Early Evaluation Program (KEEP) and the public health problem. Am J Kidney Dis 53[Suppl 3]: S107–S114, 2009
13. Minnings K, Kerns E, Fiore M, Fiore M, Parekh RS, DuBois J, Isbell TS, Ferguson R, Fiore L: Chronic kidney disease prevalence in Rivas, Nicaragua: use of a field device for creatinine measurement. Clin Biochem 48: 456–458, 2015
14. Schnabl KL, Bagherpoor S, Diker P, Cursio C, Dubois J, Yip PM: Evaluation of the analytical performance of the Nova StatSensor creatinine meter and reagent strip technology for whole blood testing. Clin Biochem 43: 1026–1029, 2010
15. Shephard M, Peake M, Corso O, Shephard A, Mazzachi B, Spaeth B, Barbara J, Mathew T: Assessment of the Nova StatSensor whole blood point-of-care creatinine analyzer for the measurement of kidney function in screening for chronic kidney disease. Clin Chem Lab Med 48: 1113-1119, 2010
16. Korpi-Steiner NL, Williamson EE, Karon BS: Comparison of three whole blood creatinine methods for estimation of glomerular filtration rate before radiographic contrast administration. Am J Clin Pathol 132: 920–926, 2009
17. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, Ckd EPI; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration): A new equation to estimate glomerular filtration rate. Ann Intern Med 150: 604–612, 2009
18. StataCorp: Stata Statistical Software: Release 12, College Station, TX, StataCorp LP, 2011
19. Gao S, Manns BJ, Culleton BF, Tonelli M, Quan H, Crowshoe L, Ghali WA, Svenson LW, Hemmelgarn BR; Alberta Kidney Disease Network: Prevalence of chronic kidney disease and survival among aboriginal people. J Am Soc Nephrol 18: 2953–2959, 2007
20. Zhang QL, Rothenbacher D: Prevalence of chronic kidney disease in population-based studies: systematic review. BMC Public Health 8: 117, 2008
21. Imai E, Yamagata K, Iseki K, Iso H, Horio M, Mkino H, Hishida A, Matsuo S: Kidney disease screening program in Japan: history, outcome, and perspectives. Clin J Am Soc Nephrol 2: 1360– 1366, 2007
22. Brown WW, Peters RM, Ohmit SE, Keane WF, Collins A, Chen SC, King K, Klag MJ, Molony DA, Flack JM: Early detection of kidney disease in community settings: the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis 42: 22–35, 2003
23. Hoy WE, Wang Z, Baker PR, Kelly AM: Reduction in natural death and renal failure from a systematic screening and treatment program in an Australian Aboriginal community. Kidney Int Suppl (83, Supplement): S66–S73, 2003
24. Barry Lavallee CC, McLeod L, Rigatto C, Tangri N, Dart A, Gordon A, Ophey S, Komenda P: Mass screening for chronic kidney disease in rural and remote Canadian first nations people: methodology and demographic characteristics. Can J Kidney Health Dis 2: 9, 2015
25. Whaley-Connell AT, Sowers JR, Stevens LA, McFarlane SI, Shlipak MG, Norris KC, Chen SC, Qiu Y, Wang C, Li S, Vassalotti JA, Collins AJ; Kidney Early Evaluation Program Investigators: CKD in the United States: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004. Am J Kidney Dis 51[Suppl 2]: S13–S20, 2008
26. Oleckno WA: Epidemiology: Concepts and Methods, Long Grove, IL, Waveland Press, Inc., 2008